These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 874815

  • 21. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR, Boccagno JA, Steinbacher TE, Horovitz ZP, Murthy VS.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [Abstract] [Full Text] [Related]

  • 22. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF, Buckley JP.
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
    Lovinger R, Holland J, Kaplan S, Grumbach M, Boryczka AT, Shackelford R, Salmon J, Reid IA, Ganong WF.
    Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
    [Abstract] [Full Text] [Related]

  • 24. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
    Montier F, Katchadourian P, Pratz J, Cavero I.
    J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF, Fernstrom JD.
    Endocrinology; 1977 Aug; 101(2):469-74. PubMed ID: 560295
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
    Rose S, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1993 Aug; 45(8):725-30. PubMed ID: 7901371
    [Abstract] [Full Text] [Related]

  • 37. Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
    Lightman SL.
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):45-52. PubMed ID: 7030527
    [Abstract] [Full Text] [Related]

  • 38. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle.
    Deleu D, Sarre S, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):576-81. PubMed ID: 8133901
    [Abstract] [Full Text] [Related]

  • 39. Action of phenytoin, ethosuximide and of the carbidopa-L-dopa association in semi-chronic cobalt-induced epilepsy in the rat.
    Scuvee-Moreau J, Lepot M, Brotchi J, Gerebtzoff MA, Dresse A.
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):92-9. PubMed ID: 603313
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.